Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
November 18, 2009

EraGen and Illumina Enter Cross-Licensing Deal for Molecular Diagnostics

  • EraGen Biosciences and Illumina are combining technologies to advance molecular diagnostic offerings. EraGen Biosciences will have access to Illumina’s BeadXpress platform for the development and commercialization of molecular-based, high-throughput clinical multiplexed assays with its own MultiCode®-PLx technology. Illumina has licensed EraGen’s MultiCode-PLx platform for the life sciences, research, and clinical markets.

Related content

  • You’re all set! Thank you for subscribing to GEN Highlights.